Ilyang Pharmaceutical company was selected as the final on the vaccine contest for a new type of influenza H7N9

Ilyang Pharmaceutical (CEO Kim, Dong-Youn) was selected as the final on the vaccine contest for a new type of influenza H7N9 from 'Governmental department business unit for new influenza'.

Ilyang has proceeded with fundamental research of H7N9 avian influenza extensively, and has prepared rapid vaccine production, equipped with vaccine production plant which can produce 60 million doses of vac...